At nCode, we are revolutionizing RNA therapeutics with our innovative Sequences as a Service (SQAAS) platform. By leveraging advanced AI, machine learning, and deep learning technologies, we significantly reduce the time from discovery to preclinical stages. Our cutting-edge nCode_Synapse AI engine generates high-quality therapeutic sequences, enhances target selection, and forecasts immunogenicity.
We continuously refine sequence modifications for stability and functionality through proprietary models, while deep learning predicts translational efficiency, target cell specificity, and drug interactions. With our large-scale multi-omic analysis, comprehensive library of optimized sequences, and state-of-the-art robotic wet lab automation, nCode is a transformative force in accelerating next-generation RNA therapeutics.
Partner with us to leverage our advanced technologies and push the boundaries of precision health. Together, we can transform the landscape of healthcare, delivering life-changing treatments to patients worldwide. Join leading big pharma, biotech, and diagnostic companies in pioneering the future of RNA medicine with nCode.
